• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Coya taps familiar friend Dr. Reddy’s to commercialize ALS med

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 06, 2023 at 09:02: PM
via Neurodegenerative biotech Coya Therapeutics has handed over key commercialization rights to an amyotrophic lateral sclerosis prospect to existing partner Dr. Reddy’s, and it's also fundraising off the deal.

article source
 




Top Bottom
Back
Quote